Menu
Enrolling by invitation NCT06776822

The Effect of DNS Therapy on Asymmetry in Children After Surgery of Congenital Heart Disease

No phase Interventional Congenital Heart Disease in Children

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Dynamic neuromuscular stabilisation.
Who it may be relevant to
Registry conditions: Congenital Heart Disease in Children. Basic parameters: 6 years — 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Czechia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of DNS Therapy in Children After Cardiac Surgery

Overview

This thesis will examine the consequences of congenital heart disease (CHD) surgery in children. The main goal of this work is to point out the possible development of late consequences after cardiac surgery in childhood (e.g. asymmetry, scoliosis, hypomobility of the spine) and to assess the effect of DNS therapy on the resolution of the consequences. For patients, after an intensive three-week rehabilitation intervention, an improvement in the monitored initial parameters is expected, which would lead to an improvement in the quality of life.

Detailed description

As part of the diploma thesis, a study will be conducted in patients after cardiac surgery performed at the Motol Hospital within the Children's Cardiology Center. The intervention will be performed in Rehabilitation Clinic Teplice nad Bečvou. The study group will include children aged 6-18 years after VSV surgery without other serious health complications. The subjects will undergo therapy according to DNS for 3 weeks. Therapy according to DNS will take place twice a day (1x individual physiotherapy 40 minutes, 1x group 40 minutes) and will be supplemented with conventional therapy (e.g. scar care).

The initial examination will be performed by a doctor and a trained physiotherapist in a blinded mode (information about which patients are undergoing the intervention will not be known). The initial examination will include imaging of the spine, ideally EOS (low radiation exposure). During the initial and final examination, a trunk stabilization examination will be performed according to the DNS protocol with photo documentation, the values of MIP and MEP oral pressures (cm H₂O) will be measured, the symmetry index will be measured using the SCODIAC software, the mobility of the spine will be examined (Schober distance, Stibor distance, Otto inclination distance, Thomayer distance, in cm) and the respiratory amplitudes on the chest will be measured (mesosternal and xiphosternal, in cm). The subjects will complete the SF-36 quality of life questionnaire before the start of therapy and after its completion. The parameters will be compared during the initial and final examination.

Interventions

  • Other Dynamic neuromuscular stabilisation
    The nervous system establishes programs that control human posture, movement and gait. This 'motor control' is largely established during the first critical years of life. Therefore, the "Prague School" emphasizes neurodevelopmental aspects of motor control in order to assess and restore dysfunction of the locomotor system and associated syndromes.

Primary outcome measures

  • Mobility of the spine - Stibor distance [Time frame: From enrollment to the end of treatment at 3 weeks]
  • Mobility of the spine - Otto's inclination distance [Time frame: From enrollment to the end of treatment at 3 weeks]
Secondary outcome measures (2)
  • Maximal and minimal expiratory pressure [Time frame: From enrollment to the end of treatment at 3 weeks]
  • Anterior trunk symmetry index (ATSI) [Time frame: From enrollment to the end of treatment at 3 weeks]

Eligibility criteria

Inclusion criteria

  • children 6-18 years, surgery of congenital heart disease

Exclusion criteria

  • any other disease

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Czechia · 1 center
  • Motol University Hospital — Prague

Identifiers

NCT: NCT06776822 · EK-714/24

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗